(GMCR, STEM, DSCO) CRWENewswire.com Stocks In Action – Video

Posted: Published on February 7th, 2012

This post was added by Dr. Richardson



02-02-2012 11:09 Good Morning, It's Thursday February 2nd, 2012, I'm Christina Collins with CRWENewswire Stocks In Action StemCells Incorporated - symbol STEM - reported that the FDA has authorized the initiation of a Phase I/II clinical trial of the Company's proprietary HuCNS-SC product candidate (purified human neural stem cells) in dry age-related macular degeneration On its first quarter fiscal 2012, Green Mountain Coffee Roasters Incorporated - symbol GMCR - posted GAAP operating income of $145.8 million, compared to $23.3 million in the same period the prior year and lastly; Discovery Laboratories Incorporated - symbol DSCO - reported that AFECTAIR is now registered with the FDA and is cleared to be marketed in the United States. AFECTAIR is a proprietary patient interface technology that simplifies delivery of aerosolized medications to patients requiring ventilator support. Thank you for joining me andhave a great day! For CRWE Newswire, Stocks In Action, I'm Christina Collins ********************************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. crwenewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (Read more at http://www.crwenewswire.com is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability ...

Original post:
(GMCR, STEM, DSCO) CRWENewswire.com Stocks In Action - Video

Related Posts
This entry was posted in FDA Stem Cell Trials. Bookmark the permalink.

Comments are closed.